1	Regulation	Regulation	B-NP	NN	O	0	ROOT	16	Regulation
2	of	of	B-PP	IN	O	1	NMOD	0
3	thrombospondin-1	thrombospondin-1	B-NP	NN	B-protein	2	PMOD	0
4	by	by	B-PP	IN	O	1	NMOD	0
5	natural	natural	B-NP	JJ	O	8	NMOD	0
6	and	and	I-NP	CC	O	8	NMOD	0
7	synthetic	synthetic	I-NP	JJ	O	8	NMOD	0
8	progestins	progestin	I-NP	NNS	O	4	PMOD	0
9	in	in	B-PP	IN	O	8	NMOD	0
10	human	human	B-NP	JJ	B-cell_type	13	NMOD	0
11	breast	breast	I-NP	NN	I-cell_type	13	NMOD	0
12	cancer	cancer	I-NP	NN	I-cell_type	13	NMOD	0
13	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	0
14	.	.	O	.	O	1	P	0

1	Our	Our	B-NP	PRP$	O	3	NMOD	0
2	recent	recent	I-NP	JJ	O	3	NMOD	0
3	studies	study	I-NP	NNS	O	4	SUB	0
4	show	show	B-VP	VBP	O	0	ROOT	0
5	that	that	B-SBAR	IN	O	4	VMOD	0
6	progestins	progestin	B-NP	NNS	O	7	SUB	0
7	induce	induce	B-VP	VBP	O	5	SBAR	17	induce
8	vascular	vascular	B-NP	JJ	B-protein	11	NMOD	0
9	endothelial	endothelial	I-NP	JJ	I-protein	11	NMOD	0
10	growth	growth	I-NP	NN	I-protein	11	NMOD	0
11	factor	factor	I-NP	NN	I-protein	7	OBJ	0
12	(	(	O	(	O	14	DEP	0
13	VEGF	VEGF	B-NP	NN	B-protein	14	DEP	0
14	)	)	O	)	O	11	NMOD	0
15	in	in	B-PP	IN	O	7	VMOD	0
16	breast	breast	B-NP	NN	B-cell_type	18	NMOD	0
17	cancer	cancer	I-NP	NN	I-cell_type	18	NMOD	0
18	cells	cell	I-NP	NNS	I-cell_type	15	PMOD	0
19	that	that	B-NP	WDT	O	18	NMOD	0
20	express	express	B-VP	VBP	O	19	SBAR	9	express
21	mutant	mutant	B-NP	JJ	B-protein	23	NMOD	0
22	p53	p53	I-NP	NN	I-protein	23	NMOD	0
23	protein	protein	I-NP	NN	I-protein	20	OBJ	0
24	.	.	O	.	O	4	P	0

1	Here	Here	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	we	we	B-NP	PRP	O	4	SUB	0
4	show	show	B-VP	VBP	O	0	ROOT	0
5	that	that	B-SBAR	IN	O	4	VMOD	0
6	natural	natural	B-NP	JJ	O	9	NMOD	0
7	and	and	I-NP	CC	O	9	NMOD	0
8	synthetic	synthetic	I-NP	JJ	O	9	NMOD	0
9	progestins	progestin	I-NP	NNS	O	11	SUB	0
10	also	also	B-ADVP	RB	O	11	VMOD	0
11	induce	induce	B-VP	VBP	O	5	SBAR	17	induce
12	thrombospondin-1	thrombospondin-1	B-NP	NN	B-RNA	16	NMOD	0
13	(	(	O	(	I-RNA	16	NMOD	0
14	TSP-1	TSP-1	B-NP	NN	I-RNA	16	NMOD	0
15	)	)	O	)	I-RNA	16	NMOD	0
16	mRNA	mRNA	B-NP	NN	I-RNA	18	NMOD	0
17	and	and	I-NP	CC	O	18	NMOD	0
18	protein	protein	I-NP	NN	O	11	OBJ	0
19	in	in	B-PP	IN	O	11	VMOD	0
20	T47-D	T47-D	B-NP	NN	B-cell_line	25	NMOD	0
21	and	and	I-NP	CC	I-cell_line	25	NMOD	0
22	BT-474	BT-474	I-NP	NN	I-cell_line	25	NMOD	0
23	breast	breast	I-NP	NN	I-cell_line	25	NMOD	0
24	cancer	cancer	I-NP	NN	I-cell_line	25	NMOD	0
25	cells	cell	I-NP	NNS	I-cell_line	19	PMOD	0
26	.	.	O	.	O	4	P	0

1	Antiprogestin	Antiprogestin	B-NP	NNP	O	2	NMOD	0
2	RU-486	RU-486	I-NP	NNP	O	3	SUB	0
3	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	18	inhibits
4	the	the	B-NP	DT	O	5	NMOD	0
5	induction	induction	I-NP	NN	O	3	OBJ	17	induction
6	of	of	B-PP	IN	O	5	NMOD	0
7	VEGF	VEGF	B-NP	NN	B-protein	9	NMOD	0
8	and	and	I-NP	CC	O	9	NMOD	0
9	TSP-1	TSP-1	I-NP	NN	B-protein	6	PMOD	0
10	by	by	B-PP	IN	O	3	VMOD	0
11	progestins	progestin	B-NP	NNS	O	10	PMOD	0
12	,	,	O	,	O	3	P	0
13	suggesting	suggest	B-VP	VBG	O	3	VMOD	0
14	that	that	B-SBAR	IN	O	13	VMOD	0
15	this	this	B-NP	DT	O	16	NMOD	0
16	effect	effect	I-NP	NN	O	19	SUB	0
17	of	of	B-PP	IN	O	16	NMOD	0
18	progestin	progestin	B-NP	NN	O	17	PMOD	0
19	is	be	B-VP	VBZ	O	14	SBAR	0
20	mediated	mediate	I-VP	VBN	O	19	VC	16	mediated
21	by	by	B-PP	IN	O	20	VMOD	0
22	the	the	B-NP	DT	O	24	NMOD	0
23	progesterone	progesterone	I-NP	NN	B-protein	24	NMOD	0
24	receptor	receptor	I-NP	NN	I-protein	21	PMOD	0
25	(	(	O	(	O	27	DEP	0
26	PR	PR	B-NP	NN	B-protein	27	DEP	0
27	)	)	O	)	O	24	NMOD	0
28	.	.	O	.	O	3	P	0

1	Actinomycin-D	Actinomycin-D	B-NP	NN	O	5	NMOD	0
2	,	,	O	,	O	5	P	0
3	but	but	O	CC	O	5	NMOD	0
4	not	not	O	RB	O	3	DEP	0
5	puromycin	puromycin	B-NP	NN	O	8	SUB	0
6	,	,	O	,	O	5	P	0
7	also	also	B-ADVP	RB	O	8	VMOD	0
8	blocks	block	B-VP	VBZ	O	0	ROOT	18	blocks
9	progestin-dependent	progestin-dependent	B-NP	JJ	O	10	NMOD	17	dependent
10	induction	induction	I-NP	NN	O	8	OBJ	17	induction
11	of	of	B-PP	IN	O	10	NMOD	0
12	TSP-1	TSP-1	B-NP	NN	B-protein	11	PMOD	0
13	.	.	O	.	O	8	P	0

1	A	A	B-NP	DT	O	4	NMOD	0
2	putative	putative	I-NP	JJ	B-DNA	4	NMOD	0
3	progestin-response	progestin-response	I-NP	JJ	I-DNA	4	NMOD	0
4	element	element	I-NP	NN	I-DNA	5	SUB	0
5	was	be	B-VP	VBD	O	0	ROOT	0
6	identified	identify	I-VP	VBN	O	5	VC	0
7	in	in	B-PP	IN	O	6	VMOD	0
8	the	the	B-NP	DT	O	11	NMOD	0
9	human	human	I-NP	JJ	B-DNA	11	NMOD	0
10	TSP-1	TSP-1	I-NP	NN	I-DNA	11	NMOD	0
11	promoter	promoter	I-NP	NN	I-DNA	7	PMOD	0
12	,	,	O	,	O	11	P	0
13	which	which	B-NP	WDT	O	11	NMOD	0
14	is	be	B-VP	VBZ	O	13	SBAR	0
15	consistent	consistent	B-ADJP	JJ	O	14	PRD	0
16	with	with	B-PP	IN	O	15	AMOD	0
17	the	the	B-NP	DT	O	18	NMOD	0
18	hypothesis	hypothesis	I-NP	NN	O	16	PMOD	0
19	that	that	B-SBAR	IN	O	18	NMOD	0
20	a	a	B-NP	DT	O	22	NMOD	0
21	progestin-PR	progestin-PR	I-NP	NN	B-protein	22	NMOD	0
22	complex	complex	I-NP	NN	I-protein	23	SUB	0
23	might	might	B-VP	MD	O	19	SBAR	0
24	directly	directly	I-VP	RB	O	23	VMOD	0
25	regulate	regulate	I-VP	VB	O	23	VC	16	regulate
26	transcription	transcription	B-NP	NN	O	25	OBJ	10	transcription
27	of	of	B-PP	IN	O	26	NMOD	0
28	the	the	B-NP	DT	O	30	NMOD	0
29	TSP-1	TSP-1	I-NP	NN	B-DNA	30	NMOD	0
30	gene	gene	I-NP	NN	I-DNA	27	PMOD	0
31	in	in	B-PP	IN	O	26	NMOD	0
32	human	human	B-NP	JJ	B-cell_type	33	NMOD	0
33	cells	cell	I-NP	NNS	I-cell_type	31	PMOD	0
34	.	.	O	.	O	5	P	0

1	Conditioned	Conditioned	B-NP	JJ	O	2	NMOD	0
2	medium	medium	I-NP	NN	O	8	SUB	0
3	from	from	B-PP	IN	O	2	NMOD	0
4	progestin-treated	progestin-treated	B-NP	JJ	B-cell_type	7	NMOD	19	treated
5	breast	breast	I-NP	NN	I-cell_type	7	NMOD	0
6	cancer	cancer	I-NP	NN	I-cell_type	7	NMOD	0
7	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	0
8	stimulates	stimulate	B-VP	VBZ	O	0	ROOT	17	stimulates
9	endothelial	endothelial	B-NP	JJ	B-cell_type	11	NMOD	0
10	cell	cell	I-NP	NN	I-cell_type	11	NMOD	0
11	proliferation	proliferation	I-NP	NN	O	8	OBJ	1	proliferation
12	in	in	B-PP	IN	O	8	VMOD	0
13	the	the	B-NP	DT	O	14	NMOD	0
14	absence	absence	I-NP	NN	O	12	PMOD	0
15	though	though	B-SBAR	IN	O	8	VMOD	0
16	not	not	O	RB	O	15	DEP	0
17	in	in	B-PP	IN	O	16	NMOD	0
18	the	the	I-PP	DT	O	17	PMOD	0
19	presence	presence	I-PP	NN	O	17	PMOD	0
20	of	of	I-PP	IN	O	17	PMOD	0
21	antibody	antibody	B-NP	NN	O	17	PMOD	0
22	to	to	B-PP	TO	O	21	NMOD	0
23	TSP-1	TSP-1	B-NP	NN	B-protein	22	PMOD	0
24	,	,	O	,	O	8	P	0
25	indicating	indicate	B-VP	VBG	O	8	VMOD	0
26	that	that	B-SBAR	IN	O	25	VMOD	0
27	TSP-1	TSP-1	B-NP	NN	B-protein	33	SUB	0
28	secreted	secrete	B-VP	VBN	O	27	NMOD	14	secreted
29	by	by	B-PP	IN	O	28	VMOD	0
30	breast	breast	B-NP	NN	B-cell_type	32	NMOD	0
31	cancer	cancer	I-NP	NN	I-cell_type	32	NMOD	0
32	cells	cell	I-NP	NNS	I-cell_type	29	PMOD	0
33	could	could	B-VP	MD	O	26	SBAR	0
34	be	be	I-VP	VB	O	33	VC	0
35	pro-angiogenic	pro-angiogenic	B-ADJP	JJ	O	34	PRD	3	angiogenic
36	.	.	O	.	O	8	P	0

1	Since	Since	B-SBAR	IN	O	17	VMOD	0
2	tumor	tumor	B-NP	NN	B-protein	4	NMOD	0
3	cell-derived	cell-derived	I-NP	JJ	I-protein	2	AMOD	0
4	TSP-1	TSP-1	I-NP	NN	I-protein	5	SUB	0
5	has	have	B-VP	VBZ	O	1	SBAR	0
6	the	the	B-NP	DT	O	7	NMOD	0
7	potential	potential	I-NP	NN	O	5	OBJ	0
8	to	to	B-VP	TO	O	9	VMOD	0
9	promote	promote	I-VP	VB	O	7	NMOD	17	promote
10	angiogenesis	angiogenesis	B-NP	NN	O	9	OBJ	3	angiogenesis
11	in	in	B-PP	IN	O	9	VMOD	0
12	the	the	B-NP	DT	O	14	NMOD	0
13	tumor	tumor	I-NP	NN	O	14	NMOD	0
14	microenvironment	microenvironment	I-NP	NN	O	11	PMOD	0
15	,	,	O	,	O	17	P	0
16	it	it	B-NP	PRP	O	17	SUB	0
17	could	could	B-VP	MD	O	0	ROOT	0
18	be	be	I-VP	VB	O	17	VC	0
19	a	a	B-NP	DT	O	21	NMOD	0
20	potential	potential	I-NP	JJ	O	21	NMOD	0
21	target	target	I-NP	NN	O	18	PRD	0
22	for	for	B-PP	IN	O	21	NMOD	0
23	breast	breast	B-NP	NN	O	25	NMOD	0
24	cancer	cancer	I-NP	NN	O	25	NMOD	0
25	therapy	therapy	I-NP	NN	O	22	PMOD	19	therapy
26	.	.	O	.	O	17	P	0

